CombiGene AB (publ) (“CombiGene”, the “Company”) hereby reminds its shareholders to attend the Extraordinary General Meeting (the “EGM”) to be held on December 10, 2024 at 13.30 CET via digital connection. Registration starts at 13.00 CET.
The notice to attend the EGM is available on CombiGene’s web site. At the EGM, shareholders will have two different proposals to decide on, one from the Board of CombiGene and one from the largest shareholder of the Company, Strategic Partners A / S. The proposals have been presented in a press release on October 31 and in a webinar on November 28 (in Swedish).
Shareholders that wish to participate in the EGM shall be registered in the share register maintained by Euroclear Sweden AB no later than on December 2, 2024 and shall have notified the Company of their intention to participate at the EGM no later than on December 4, 2024. Notice to participate shall be given in writing by e-mail to combigene@fredersen.se or by post to CombiGene AB, c/o Fredersen Advokatbyrå, Birger Jarlsgatan 8, SE-114 34 Stockholm. The notice shall contain the shareholder’s name, personal identity number or registration number, email address and telephone number and, where applicable, the number of assistants (maximum two).